BAFF And Its Receptors:contribution And Therapeutic Potential In Atherosclerosis
Funder
National Health and Medical Research Council
Funding Amount
$562,742.00
Summary
Atherosclerosis is an inflammatory reaction to cholesterol in blood vessels. Despite cholesterol-lowering statins, atherosclerosis-based heart attacks and strokes remain a major cause of deaths. Studies of BAFF, a pro-inflammatory molecule can shed new light on the inflammation. As BAFF blockers are already in clinical trials to treat inflammatory diseases, our study has potential to lead to using BAFF blockers to treat human atherosclerosis.